News for HAVLF Stock

HAVN Life To Be Featured On Viewpoint with Dennis Quaid HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022 HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility HAVN Life Natural Health Products Now Available on Amazon.ca HAVN Life Signs Agreement to Enable Export of Psilocybin into Canada, the US and Europe HAVN Life Signs Exclusive Supply Agreement With Cube Psytech HAVN Life Sciences Signs Finished Goods Supply Agreement with Allied Health HAVN Life Announces Retail Partnership with Grocer, Choices Markets HAVN Life Launches New Line of Natural Health Products HAVN Life Completes Acquisition of Clinical Stage IP for Development of Cluster Headache Drug HAVN Life Secures Production & Supply Agreement to Expand Retail Product Offerings HAVN Life Enters into Agreement to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches Havn Life CEO Tim Moore to Appear at Upcoming Q2 Investor SummitHavn Life CEO Tim Moore to Appear at Upcoming Q2 Investor Summit Havn Life Signs Exclusive Supply Agreement with ATMA Journey Centers Havn Life Develops New Method for Rapid Psilocybin Testing Havn Labs Jamaica Facility Now Fully Operational Havn Life Completes Acquisition of Strategic Manufacturing & Packaging Facility for its Retail Division Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness Havn Life CEO to Present at Zooming with LD, a Leading Platform for Microcap Companies Havn Life Introduces Industry Leader Jenna Pozar as Chief Operating Officer Havn Life Sciences to Host Investor Webcast on March 3, 2021 Havn Life Announces DTC Eligibility of Its Common Shares in the United States Havn Life Announces Changes to Board Composition and Departure of Ms. Rasode Havn Life Launches a Range of Natural Health Products